NU-MED PLUS, INC. (OTCMKTS:NUMD) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.

See Item 8.01.

The information contained in this Item 7.01 and in Exhibit 99 is being furnished, and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under such Section 18.  Furthermore, the information contained in this Item 7.01 and in Exhibit 99 shall not be deemed to be incorporated by reference into our filings under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act.

Item 8.01 Other Events.

On March 16, 2017 the Company filed a complaint against a former Consultant and Officer related to consulting agreements and the return of unearned shares.  The Company is requesting the return of such unearned shares.

The former Officer and Consultant has filed a claim against the Company and its President relating to these shares.

The Company will vigorously prosecute and defend there claim which requests the return of unearned shares.

We have issued a Press Release dated March 28, 2017 regarding this complaint.  The Press Release is attached to this 8-K as Exhibit 99, see Item 9.01.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Table #

Title of Document

Location

Press Release dated March 28, 2017

This Filing

About NU-MED PLUS, INC. (OTCMKTS:NUMD)

NU-MED PLUS, INC. (NU-MED) is an early stage company, which is engaged in developing, manufacturing and marketing technologies in the medical device field. The Company intends to become a medical device company principally engaged in the design, development, enhancement and commercialization of beginning, early, and selective later-stage medical devices. The Company focuses on the creation of a nitric oxide powder formulation, a hospital bedside nitric oxide generator and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community around the world. NU-MED has developed a prototype lightweight Portable NO Delivery System that can be worn by patients outside of the hospital setting for underserved chronic therapies, and for applications within the United States and in developing nations. The Company has not generated any revenues.

NU-MED PLUS, INC. (OTCMKTS:NUMD) Recent Trading Information

NU-MED PLUS, INC. (OTCMKTS:NUMD) closed its last trading session 00.000 at 0.400 with shares trading hands.